S&P
OrganizationRelationship Network
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| N/A | N/A | Q2 earnings season in the US. | US | View |
HOUSE_OVERSIGHT_025288.jpg
This document is a UBS investment presentation slide titled 'Private equity' from October 2012 (slide 41). It provides a market outlook comparing US and European markets, recommending small/mid-cap buyouts in the US and distressed debt strategies in Europe due to the Eurozone debt crisis. The document bears a 'HOUSE_OVERSIGHT_025288' stamp, indicating it was produced as part of a Congressional investigation, likely related to financial institutions' relationships with individuals such as Jeffrey Epstein.
HOUSE_OVERSIGHT_025246.jpg
This document is page 5 of a J.P. Morgan 'Eye on the Market' report dated April 9, 2012, authored by CIO Michael Cembalest. The report discusses US market valuations (P/E multiples) and expresses significant concern regarding Spain's economic stability compared to other European nations like Greece and Ireland. The document bears a Bates stamp 'HOUSE_OVERSIGHT_025246', indicating it was obtained during a House Oversight Committee investigation, likely regarding J.P. Morgan's internal records.
HOUSE_OVERSIGHT_025219.jpg
This document analyzes the European financial situation, criticizing EU bank stress tests and policy moves towards federalization, while pivoting to investment advice favoring US large cap growth stocks due to attractive valuations. It also reviews the Q2 US earnings season, noting positive results but flattening growth expectations, and includes a critical quote from Bundesbank President Weidmann regarding Euro area risk sharing.
HOUSE_OVERSIGHT_024768.jpg
This document is page 132 of a December 2017 Cannabis Investment Report by Ackrell Capital, LLC. It provides a detailed comparison of Canadian stock markets (TSX, TSXV, and CSE) regarding their suitability for cannabis-related companies, listing requirements, and market values. The document bears a 'HOUSE_OVERSIGHT_024768' Bates stamp, indicating it was part of a document production to the House Oversight Committee, though no specific individuals (Epstein or otherwise) are named in the text of this specific page.
HOUSE_OVERSIGHT_024766.jpg
This document is page 130 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital, LLC. It provides financial data tables for cannabis companies listed on the Toronto Stock Exchange (TSX) and TSX Venture Exchange, including stock prices, market values, and revenue multiples as of November 30, 2017. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024766', indicating it was surrendered to the House Oversight Committee during an investigation.
HOUSE_OVERSIGHT_024765.jpg
This document is page 129 of a financial report by Ackrell Capital, LLC, titled 'Chapter VII Capital Markets for Cannabis Companies'. It presents a bar chart and table analyzing capital raised by Canadian publicly traded cannabis companies for the Last Twelve Months (LTM) ended September 30, 2017, sourced from S&P Global Market Intelligence. While part of a House Oversight document dump (indicated by Bates stamp HOUSE_OVERSIGHT_024765), the page contains purely financial market metrics regarding the TSX, TSXV, and CSE exchanges and names no specific individuals.
HOUSE_OVERSIGHT_024764.jpg
This document is page 128 of a December 2017 Cannabis Investment Report by Ackrell Capital. It features a line graph tracking Canadian Cannabis Stock Price Performance against various indices from September 2016 to November 2017, highlighting market events such as the PM's legalization announcement and Constellation Brands' investment in Canopy Growth. The page bears the Bates stamp HOUSE_OVERSIGHT_024764, indicating it is part of a larger production of documents, likely related to congressional oversight, though no specific connection to Jeffrey Epstein or his associates is visible in the text of this specific page.
HOUSE_OVERSIGHT_024763.jpg
This document is page 127 of a report by Ackrell Capital titled 'Capital Markets for Cannabis Companies.' It provides a financial summary of Canadian publicly traded cannabis-related companies as of November 30, 2017, including market value and revenue data for companies on the TSX, TSXV, and CSE. The text also references the positive market impact of Prime Minister Justin Trudeau's legislative announcements and an investment by Constellation Brands into Canopy Growth. The document bears a 'HOUSE_OVERSIGHT' Bates stamp.
HOUSE_OVERSIGHT_024762.jpg
This document is page 126 from a December 2017 Cannabis Investment Report by Ackrell Capital. It features a detailed comparison table of U.S. stock markets (Nasdaq, NYSE, and OTC), analyzing them by tiers, listed companies, market value, and regulatory requirements. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024762', indicating it was obtained during a House Oversight Committee investigation, likely related to financial records involving major banks or investment firms.
HOUSE_OVERSIGHT_024760.jpg
This document is page 124 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It contains financial tables listing market data (stock price, market value, enterprise value, revenue, EBITDA) for various cannabis-related companies listed on Nasdaq, NYSE, and AMEX as of November 30, 2017. The document bears a 'HOUSE_OVERSIGHT_024760' stamp, indicating it is part of a larger production of documents to the House Oversight Committee.
HOUSE_OVERSIGHT_024759.jpg
This document is page 123 of a report by Ackrell Capital regarding capital markets for cannabis companies, bearing a House Oversight Bates stamp. It presents statistical data on capital raised by U.S. publicly traded cannabis companies for the twelve months ending September 30, 2017, breaking down amounts by exchange (Nasdaq, NYSE, OTC). While part of a document production likely related to broader financial investigations (possibly involving banks linked to Epstein), this specific page contains no direct references to Jeffrey Epstein or his associates.
HOUSE_OVERSIGHT_024758.jpg
This document is page 122 of a December 2017 Cannabis Investment Report by Ackrell Capital. It provides a financial summary and stock price performance analysis of U.S. publicly traded cannabis-related companies as of November 2017. The report notes that the election of Donald Trump and the confirmation of Jeff Sessions did not negatively impact the stock performance of these companies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production to Congress.
HOUSE_OVERSIGHT_024757.jpg
This page from an Ackrell Capital report details capital raised by publicly traded cannabis companies for the year ending September 30, 2017, highlighting that Canadian companies raised significantly more capital than those in the U.S. or Australia. It also provides an overview of the U.S. public capital markets for cannabis, noting that while a few trade on major exchanges like Nasdaq and NYSE, the vast majority are "penny" stocks on the OTC market characterized by high risk and regulatory scrutiny from the SEC and FINRA.
HOUSE_OVERSIGHT_024756.jpg
This document is page 120 of a December 2017 Cannabis Investment Report by Ackrell Capital. It analyzes the stock price performance and capital raising activities of cannabis-related companies in the U.S., Canada, and Australia, noting resilience despite U.S. political changes (Trump/Sessions) and growth driven by Canadian legislation and strategic investments. The document bears a 'HOUSE_OVERSIGHT' stamp, but contains no direct mentions of Jeffrey Epstein or his known associates on this specific page.
HOUSE_OVERSIGHT_024755.jpg
This document is page 119 of a report by Ackrell Capital titled 'Capital Markets for Cannabis Companies.' It analyzes listing requirements for cannabis companies on US, Canadian, and Australian stock exchanges (NYSE, Nasdaq, OTC, TSX, CSE, ASX). It includes a statistical table summarizing market values, enterprise values, and revenue averages for cannabis-related companies as of November 30, 2017. The document bears a House Oversight Committee stamp.
HOUSE_OVERSIGHT_024225.jpg
This is page 24 of a confidential 'Global Utility White Paper' produced by Electron Capital Partners, LLC. The text outlines the firm's investment research methodology regarding utility companies, specifically focusing on capital expenditure (capex) flexibility, operating expenditure (opex) cuts, and asset divestiture to predict dividend cuts and credit rating changes. The document is explicitly watermarked for the exclusive use of Jeffrey Epstein.
HOUSE_OVERSIGHT_024221.jpg
This document is Appendix 1 of a 'Global Utility White Paper' produced by Electron Capital Partners, LLC. It details the firm's investment team, led by Portfolio Manager Jos Shaver (formerly of SAC Capital), their global research process, and a 7-year performance track record. The document is explicitly marked 'For exclusive of Jeffrey Epstein' in the footer, indicating he was being pitched as an investor or was an existing client receiving confidential reports.
HOUSE_OVERSIGHT_024208.jpg
This is page 7 of a confidential 'Global Utility White Paper' produced by Electron Capital Partners, LLC, specifically marked for the exclusive use of Jeffrey Epstein. The document analyzes US utility markets, predicting they will be the least attractive for alpha generation over the next two years due to valuation concerns and flat earnings. It includes a chart sourced from Bloomberg (dated March 4, 2013) showing utility underperformance following Quantitative Easing (QE) announcements.
HOUSE_OVERSIGHT_024205.jpg
Page 4 of a confidential white paper from Electron Capital Partners, LLC, specifically marked for the exclusive use of Jeffrey Epstein. The document outlines investment strategies in the global utility sector, arguing for the sector's alpha opportunities following periods of underperformance and its diversification benefits. It references specific companies like Exelon and NRG, and compares Electron's performance metrics against indices like MSCI and HFRI.
HOUSE_OVERSIGHT_024176.jpg
A UBS 'Private Equity' market analysis slide from May 2012, labeled with a House Oversight Bates stamp (024176). The document outlines UBS's strategic recommendations, favoring small/mid-cap buyouts in North America and distressed debt in Europe due to the Eurozone crisis, while noting over $930 billion in uninvested capital in the market. It includes contact information for Stefan Brägger and financial data charts sourced from S&P.
HOUSE_OVERSIGHT_024175.jpg
This document is a UBS financial presentation slide dated June 18, 2012, analyzing hedge fund strategies amidst the Eurozone crisis. It provides strategic recommendations favoring relative value and event-driven strategies due to market volatility, while outlining positive and negative economic scenarios. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was produced as part of a congressional investigation, likely related to financial records.
HOUSE_OVERSIGHT_024108.jpg
This document is Appendix 5 (Endnotes) of a confidential financial report dated as of March 31, 2014, obtained by the House Oversight Committee (Bates stamp HOUSE_OVERSIGHT_024108). It outlines the methodology for financial performance reporting for funds identified as NLV-I, NLV-II, and the Sprout Funds, distinguishing between 'gross' and 'net' performance and providing legal disclaimers regarding valuations and future results. The document defines the roles of generic 'Fund Managers' and the 'Sprout Group' in managing these investments.
HOUSE_OVERSIGHT_029348.jpg
This document contains a Bloomberg article excerpt by Matt Levine discussing the finances and estate of 'Simmons' (likely Harold Simmons), featuring a graph comparing Valhi Inc stock to the S&P 500 from 2013-2014. The text discusses estate taxes, share calculations, and Simmons's political views and legal history with NL Industries. The document concludes with the signature block of Alan S. Halperin, a partner at Paul, Weiss, Rifkind, Wharton & Garrison LLP, and bears a House Oversight Bates stamp.
HOUSE_OVERSIGHT_029347.jpg
This document, stamped by House Oversight, appears to be a printout of a financial analysis or blog post regarding the estate of 'Simmons' (likely Harold Simmons) and the performance of Valhi Inc stock. It discusses the control of a tax-exempt Foundation by Lisa K. Simmons and Serena Simmons Connelly, contrasts them with other daughters who were 'frozen out,' and includes a chart comparing Valhi stock to the S&P 500 around the time of Simmons's death in late 2013/early 2014. The text references major institutional holders like BlackRock and Citadel and cites IRS bulletins and NYT articles.
HOUSE_OVERSIGHT_025697.jpg
This document is a standard legal disclaimer page (page 34) from a Goldman Sachs Investment Management Division presentation or report. It outlines the trademark and licensing details for various market indices (S&P, Dow Jones, MSCI, Russell, Tokyo Stock Exchange, and EURO Stoxx) referenced in the broader document. While it contains no specific information about Jeffrey Epstein, the Bates stamp 'HOUSE_OVERSIGHT_025697' indicates this page was part of a larger document production submitted to the House Oversight Committee, likely during an investigation involving financial records held by Goldman Sachs.
| Date | Type | From | To | Amount | Description | Actions |
|---|---|---|---|---|---|---|
| 0025-01-01 | Received | Donald J. Trump (... | S&P | $0.00 | Purchase | View |
| 0025-01-01 | Received | Donald J. Trump (... | S&P | $0.00 | Purchase | View |
| 0025-01-01 | Received | Donald J. Trump (... | S&P | $0.00 | Purchase of SPDR S&P 500 ETF Trust | View |
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity